Correlation Between Prime Medicine and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Prime Medicine and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine Common and Transcode Therapeutics, you can compare the effects of market volatilities on Prime Medicine and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine and Transcode Therapeutics.
Diversification Opportunities for Prime Medicine and Transcode Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Prime and Transcode is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine Common and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Prime Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine Common are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Prime Medicine i.e., Prime Medicine and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Prime Medicine and Transcode Therapeutics
Given the investment horizon of 90 days Prime Medicine is expected to generate 9.57 times less return on investment than Transcode Therapeutics. But when comparing it to its historical volatility, Prime Medicine Common is 1.17 times less risky than Transcode Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 940.00 in Transcode Therapeutics on November 9, 2025 and sell it today you would lose (49.00) from holding Transcode Therapeutics or give up 5.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.36% |
| Values | Daily Returns |
Prime Medicine Common vs. Transcode Therapeutics
Performance |
| Timeline |
| Prime Medicine Common |
| Transcode Therapeutics |
Prime Medicine and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine and Transcode Therapeutics
The main advantage of trading using opposite Prime Medicine and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Prime Medicine vs. Maravai Lifesciences Holdings | Prime Medicine vs. Kura Oncology | Prime Medicine vs. Bicara Therapeutics Common | Prime Medicine vs. Vir Biotechnology |
| Transcode Therapeutics vs. In8bio Inc | Transcode Therapeutics vs. Lyra Therapeutics | Transcode Therapeutics vs. Aptevo Therapeutics | Transcode Therapeutics vs. Galecto |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |